Cargando…

Bone Density in Chronic Schizophrenia with Long-Term Antipsychotic Treatment: Preliminary Study

OBJECTIVE: Decreased bone mineral density has been found in the chronic schizophrenic patients who have been given a long-term administration of antipsychotics. Hyperprolactinemia from the antipsychotics and the negative symptom of schizophrenia were considered as the causes for this finding. In thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Tae-Young, Chung, Moon-Yong, Chung, Hae-Kyung, Choi, Jin-Hee, Kim, Tae-Yong, So, Hyung-Seok
Formato:	Texto
Lenguaje:	English
Publicado:	Korean Neuropsychiatric Association 2010
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022315/ https://www.ncbi.nlm.nih.gov/pubmed/21253412 http://dx.doi.org/10.4306/pi.2010.7.4.278

Ejemplares similares

Long-Term Evolution of Metabolic Status in Patients with Schizophrenia Stably Maintained on Second-Generation Antipsychotics
por: Jeong, Seong Hoon, et al.
Publicado: (2018)

Effects of Long-Term Combination Treatment with Valproate and Atypical Antipsychotics on Bone Mineral Density and Bone Metabolism in Premenopausal Patients with Bipolar Disorder: A Preliminary Study
por: Yang, Jaewon, et al.
Publicado: (2011)

Antipsychotic Effects of Quetiapine in Naturalistic Long Term Follow Up Study
por: Lee, Jung-Sun, et al.
Publicado: (2010)

Effects of Antipsychotics on Bone Mineral Density in Patients with Schizophrenia: Gender Differences
por: Chen, Chien-Yu, et al.
Publicado: (2016)

Long-acting Injectable Antipsychotics in First-episode Schizophrenia
por: Jeong, Hyun-Ghang, et al.
Publicado: (2013)

Bone mineral density and bone turnover markers in patients on long-term suppressive levothyroxine therapy for differentiated thyroid cancer
por: Lee, Mi Young, et al.
Publicado: (2014)

Long-term Use of Clozapine is Protective for Bone Density in Patients with Schizophrenia
por: Lin, Chieh-Hsin, et al.
Publicado: (2019)

Long-Acting Injectable Antipsychotics for First-Episode Schizophrenia: The Pros and Cons
por: Kim, Borah, et al.
Publicado: (2012)

Application of Short Screening Tools for Post-Traumatic Stress Disorder in the Korean Elderly Population
por: Jang, Yu Jin, et al.
Publicado: (2016)

Preliminary results of a network meta-analysis on the efficacy of long-acting injectable antipsychotics in schizophrenia
por: Medrano, R., et al.
Publicado: (2021)

Atypical antipsychotics usage in long-term follow-up of first episode schizophrenia
por: Shrivastava, Amresh, et al.
Publicado: (2012)

Long-term cost-effectiveness of atypical antipsychotics in the treatment of adults with schizophrenia in the US
por: O’Day, Ken, et al.
Publicado: (2013)

Unresolved Issues for Utilization of Atypical Antipsychotics in Schizophrenia: Antipsychotic Polypharmacy and Metabolic Syndrome
por: Jeon, Sang Won, et al.
Publicado: (2017)

The Use of Long-Acting Injectable Antipsychotics in Schizophrenia
por: Miyamoto, Seiya, et al.
Publicado: (2017)

Changes in bone mineral density and trabecular bone score in Graves' disease patients after anti-thyroid therapy
por: Ock, So Young, et al.
Publicado: (2016)

Comparative Efficacy and Safety of Long-acting Injectable and Oral Second-generation Antipsychotics for the Treatment of Schizophrenia: A Systematic Review and Meta-analysis
por: Park, Seon-Cheol, et al.
Publicado: (2018)

Bone mineral density, cervical spine degeneration, head and neck posture, and neck pain in the post-menopausal females: A pilot study
por: Hong, Seok Woo, et al.
Publicado: (2021)

Bone regeneration effects of human allogenous bone substitutes: a preliminary study
por: Lee, Deok-Won, et al.
Publicado: (2010)

PM441. Long term atypical antipsychotic treatment improves cognitive performance in schizophrenia but not surpassing conventional antipsychotic drugs effects.
por: Vera, Gabriel Selva, et al.
Publicado: (2016)

Time to Rehospitalization in Patients With Schizophrenia Receiving Long-Acting Injectable Antipsychotics or Oral Antipsychotics
por: Lin, Ching-Hua, et al.
Publicado: (2019)

Long-Acting Injectable Antipsychotics in First-Episode Schizophrenia
por: Parellada, Eduard, et al.
Publicado: (2012)

Schizophrenia long-acting antipsychotics initiation index (SLAAII)
por: Ifteni, P., et al.
Publicado: (2021)

The place of long-acting injectable antipsychotics in the treatment of schizophrenia
por: Kane, John M., et al.
Publicado: (2023)

Relationship between Bone Density, Eating Habit, and Nutritional Intake in College Students
por: Lim, Hee-Sook, et al.
Publicado: (2018)

Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review
por: Karson, Craig, et al.
Publicado: (2016)

Long-term effects of antipsychotics on mortality in patients with schizophrenia: a systematic review and meta-analysis
por: Jia, Ningning, et al.
Publicado: (2022)

Association of Long-Acting Injectable Antipsychotics and Oral Antipsychotics With Disease Relapse, Health Care Use, and Adverse Events Among People With Schizophrenia
por: Wei, Yue, et al.
Publicado: (2022)

The effect of atypical antipsychotics on brain N-acetylaspartate levels in antipsychotic-naïve first-episode patients with schizophrenia: a preliminary study
por: Grošić, Vladimir, et al.
Publicado: (2014)

Short-Term Caloric Restriction Does Not Reduce Bone Mineral Density in Rats with Early Type 2 Diabetes
por: Jeon, Yun Kyung, et al.
Publicado: (2014)

Long Acting Injectable Antipsychotics in the Treatment of Schizophrenia and Bipolar Disorder
por: DEVRİMCİ ÖZGÜVEN, Halise, et al.
Publicado: (2021)

Pharmacokinetic Characteristics of Long-Acting Injectable Antipsychotics for Schizophrenia: An Overview
por: Correll, Christoph U., et al.
Publicado: (2021)

Long-Term Changes in Self-Report Auditory Verbal Hallucinations in Patients with Schizophrenia Using Clozapine
por: Chung, In Won, et al.
Publicado: (2019)

Long-term antipsychotic treatment in schizophrenia: systematic review and network meta-analysis of randomised controlled trials
por: Zhao, Ying Jiao, et al.
Publicado: (2016)

Safety and related factors of treatment with long-term atypical antipsychotic in Chinese patients with schizophrenia: observational study
por: Yu, Wenjuan, et al.
Publicado: (2021)

Inflammatory Response in SARS-CoV-2 Infection of Patients with Schizophrenia and Long-Term Antipsychotic Treatment
por: Moga, Silvia, et al.
Publicado: (2021)

Risk factors for osteoporosis in chronic schizophrenia on long-term treatment with antipsychotics: a cross-sectional study
por: Liu, Furu, et al.
Publicado: (2023)

Relationship between Heavy Metal Exposure and Bone Mineral Density in Korean Adult
por: Lim, Hee-Sook, et al.
Publicado: (2016)

PM393. Antipsychotic polypharmacy patterns and antipsychotic psychiatric medication adherence in patients with schizophrenia
por: Joe, Soohyun, et al.
Publicado: (2016)

Antipsychotic monotherapy and polypharmacy in the naturalistic treatment of schizophrenia with atypical antipsychotics
por: Faries, Douglas, et al.
Publicado: (2005)

Culturing at Low Cell Density Delays Cellular Senescence of Human Bone Marrow-Derived Mesenchymal Stem Cells in Long-Term Cultures
por: Kim, Si-Na, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vnklbi78o8n1d4qsca13gt3n60